Inventor · disambiguated record
Edwin L. Madison
Also filed as: MADISON EDWIN · MADISON EDWIN L
41 granted patents·16 pending applications·572 citations·filing 1989–2025
98Inventor score
Top patents by PatentIndex Score
57 records- 0196US9290757B2Protease screening methods and proteases identified therebyMADISON EDWIN L·Filed 2012·Granted Mar 22, 2016·30 cites·12 claims
- 0296US8663633B2Protease screening methods and proteases identified therebyMADISON EDWIN L·Filed 2012·Granted Mar 4, 2014·22 cites·20 claims
- 0396US8211428B2Protease screening methods and proteases identified therebyMADISON EDWIN L·Filed 2007·Granted Jul 3, 2012·32 cites·59 claims
- 0493US8778870B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2011·Granted Jul 15, 2014·24 cites·37 claims
- 0593US6677473B1Plasminogen activator inhibitor antagonistsCORVAS INTERNAT INC·Filed 2000·Granted Jan 13, 2004·110 cites·34 claims
- 0692US6586405B2Non-covalent inhibitors of urokinase and blood vessel formationCORVAS INT INC·Filed 2000·Granted Jul 1, 2003·39 cites·90 claims
- 0791US8519103B2Factor VII polypeptides that are modified and uses thereofMADISON EDWIN L·Filed 2009·Granted Aug 27, 2013·16 cites·71 claims
- 0888US9476037B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2013·Granted Oct 25, 2016·8 cites·30 claims
- 0985US12173337B2Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of useVERTEX PHARMA·Filed 2023·Granted Dec 24, 2024·0 cites·48 claims
- 1085US7700341B2Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereonDENDREON CORP·Filed 2001·Granted Apr 20, 2010·18 cites·38 claims
- 1185US7572444B2Binding proteins specific for human matriptaseAMGEN FREMONT INC·Filed 2005·Granted Aug 11, 2009·12 cites·17 claims
- 1284US9795655B2Modified MT-SP1 proteases that inhibit complement activationMADISON EDWIN L·Filed 2014·Granted Oct 24, 2017·7 cites·12 claims
- 1383US11203749B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2018·Granted Dec 21, 2021·1 cites·6 claims
- 1482US7273610B2Endotheliase-2 ligandsDYAX CORP·Filed 2004·Granted Sep 25, 2007·14 cites·13 claims
- 1581US10160961B2Factor VII polypeptides that are modified and uses thereofCATALYST BIOSCIENCES INC·Filed 2016·Granted Dec 25, 2018·2 cites·26 claims
- 1681US9328339B2Modified factor IX polypeptides and uses thereofMADISON EDWIN L·Filed 2014·Granted May 3, 2016·4 cites·30 claims
- 1779US6638977B1Plasminogen activator inhibitor antagonistsCORVAS INT INC·Filed 1999·Granted Oct 28, 2003·21 cites·71 claims
- 1878US11807882B2Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of useVERTEX PHARMA·Filed 2021·Granted Nov 7, 2023·0 cites·56 claims
- 1978US7172892B2Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Feb 6, 2007·11 cites·30 claims
- 2078US7112430B2Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Sep 26, 2006·11 cites·43 claims
- 2177US7888092B2Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereonDENDREON CORP·Filed 2009·Granted Feb 15, 2011·1 cites·21 claims
- 2276US5550042ASerine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the sameUNIV TEXAS·Filed 1989·Granted Aug 27, 1996·23 cites·48 claims
- 2376US5304482ASerine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitorsUNIV TEXAS·Filed 1990·Granted Apr 19, 1994·43 cites·4 claims
- 2474US12331334B2Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2023·Granted Jun 17, 2025·0 cites·65 claims
- 2573US10954501B2Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of useCATALYST BIOSCIENCES INC·Filed 2020·Granted Mar 23, 2021·0 cites·44 claims
- 2672US11401513B2Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of useCATALYST BIOSCIENCES INC·Filed 2020·Granted Aug 2, 2022·0 cites·41 claims
- 2772US7105333B2Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereonDENDREON CORP·Filed 2002·Granted Sep 12, 2006·6 cites·44 claims
- 2871US6797504B1Inhibitors of serine protease activity of matriptase or MTSP1DENDREON SAN DIEGO LLC·Filed 2000·Granted Sep 28, 2004·10 cites·4 claims
- 2970US5486602AGenes encoding serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitorsUNIV TEXAS·Filed 1993·Granted Jan 23, 1996·30 cites·5 claims
- 3070US2021230570A1Modified factor ix polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3169US10781435B2Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of useCATALYST BIOSCIENCES INC·Filed 2018·Granted Sep 22, 2020·0 cites·38 claims
- 3268US5728564AU-PA mutants resistant to inhibition by their cognate inhibitorsUNIV TEXAS·Filed 1996·Granted Mar 17, 1998·26 cites·8 claims
- 3366US2025263683A1Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2025·Application pending·0 cites
- 3464US7276364B1Nucleic acids encoding endotheliases, endotheliases and uses thereofDENDREON CORP·Filed 2000·Granted Oct 2, 2007·2 cites·32 claims
- 3563US6869778B2Tissue type plasminogen activator (t-PA) variants: compositions and methods of useSCRIPPS RESEARCH INST·Filed 2003·Granted Mar 22, 2005·0 cites·8 claims
- 3663US5866413APai-1 mutantsUNIV TEXAS·Filed 1997·Granted Feb 2, 1999·19 cites·8 claims
- 3762US10982203B2Modified factor IX polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2016·Granted Apr 20, 2021·0 cites·42 claims
- 3860US6576613B1Title inhibitors of urokinaseCORVAS INT INC·Filed 1998·Granted Jun 10, 2003·15 cites·54 claims
- 3958US2008075723A1Endotheliase 2 ligandsDYAX CORP A MASSACHUSETTS CORP·Filed 2007·Application pending·0 cites
- 4058US2008019962A1Endotheliase-2 ligandsDYAX CORP A MASSACHUSETTS CORP·Filed 2007·Application pending·0 cites
- 4156US2007093443A1Modified proteases that inhibit complement activationMADISON EDWIN L·Filed 2006·Application pending·0 cites
- 4255US2005164945A1Endotheliase-1 ligandsFiled 2004·Application pending·0 cites
- 4354US9856467B2Modified factor X polypeptides and uses thereofCATALYST BIOSCIENCES INC·Filed 2014·Granted Jan 2, 2018·0 cites·35 claims
- 4452US11613744B2Modified urokinase-type plasminogen activator polypeptides and methods of useVERTEX PHARMA·Filed 2020·Granted Mar 28, 2023·0 cites·77 claims
- 4552US9145552B2Modified factor X polypeptides and uses thereofMADISON EDWIN L·Filed 2013·Granted Sep 29, 2015·0 cites·29 claims
- 4652US2012244139A1Modified proteases that inhibit complement activationMADISON EDWIN L·Filed 2012·Application pending·0 cites
- 4751US2006029590A1Administration of neutral endopeptidase to treat inflammatory bowel diseaseTHANOS CHRISTOPHER·Filed 2005·Application pending·0 cites
- 4851US2005112579A1Nucleic acid molecules encoding serine protease 16, the encoded polypeptides and methods based thereonDENDREON SAN DIEGO LLC A DELAW·Filed 2003·Application pending·0 cites
- 4949US6706504B1Tissue type plasminogen activator (t-PA) variants: compositions and methods of useSCRIPPS RESEARCH INST·Filed 1997·Granted Mar 16, 2004·9 cites·22 claims
- 5049US2011105731A1Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereonMADISON EDWIN L·Filed 2010·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →